Focus: Lumos Pharma is a rare disease and oncology-focused pharmaceutical company headquartered in Austin, TX with a diverse pipeline spanning growth hormone deficiency, immuno-oncology, and cancer vaccines.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
A clinical-stage biotech with meaningful rare disease focus and broad oncology ambitions, but lack of financial transparency and published data requires due diligence before committing.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Lumos Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Lumos Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles